Go to content
UR Home

HDAC3 is essential for Human Leukemic Cell Growth and the Expression of β-catenin, MYC, and WT1

URN to cite this document:
DOI to cite this document:
Beyer, M. ; Romanski, A. ; Mustafa, Al-Hassan M. ; Sellmer, Andreas
License: Creative Commons Attribution 4.0
PDF - Published Version
Date of publication of this fulltext: 13 Feb 2020 08:55


Therapy of acute myeloid leukemia (AML) is unsatisfactory. Histone deacetylase inhibitors (HDACi) are active against leukemic cells in vitro and in vivo. Clinical data suggest further testing of such epigenetic drugs and to identify mechanisms and markers for their efficacy. Primary and permanent AML cells were screened for viability, replication stress/DNA damage, and regrowth capacities after ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: daten@ur.de
0941 943 -5707

Contact persons